SAFETY OF THERAPY AND PATRONAGE SYSTEM IN PATIENTS WHO RECEIVE WARFARIN
https://doi.org/10.21518/2307-1109-2015-2-124-131
Abstract
The paper discusses the most common questions regarding the safety of therapy and patronage system in patients who receive warfarin in the question and answer form. Vitamin K antagonists now are the oral anticoagulants that are most commonly used in the actual clinical practice. Despite a large accumulated body of clinical experience, it is not always easy for a doctor to pick the individual dose of warfarin.
About the Author
E. S. Kropacheva
Researcher, the Atherothrombosis Clinical Problems Laboratory of the Angiology Division of the A.L. Myasnikov Clinical Cardiology Institute RK NPK of the Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
Cand.scient.med.
Review
For citations:
Kropacheva E.S. SAFETY OF THERAPY AND PATRONAGE SYSTEM IN PATIENTS WHO RECEIVE WARFARIN. Aterotromboz = Atherothrombosis. 2015;(2):124-131. (In Russ.) https://doi.org/10.21518/2307-1109-2015-2-124-131
Views:
894
This work is licensed under a Creative Commons Attribution Attribution-NonCommercial-NoDerivs License.
Email this article 